Agilent Technologies Inc (A) : Impax Asset Management Ltd reduced its stake in Agilent Technologies Inc by 0.69% during the most recent quarter end. The investment management company now holds a total of 1,643,333 shares of Agilent Technologies Inc which is valued at $79,093,617 after selling 11,495 shares in Agilent Technologies Inc , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.Agilent Technologies Inc makes up approximately 3.74% of Impax Asset Management Ltd’s portfolio.
Other Hedge Funds, Including , Rafferty Asset Management added A to its portfolio by purchasing 13,005 company shares during the most recent quarter which is valued at $625,931. Agilent Technologies Inc makes up approx 0.04% of Rafferty Asset Management’s portfolio.Neuberger Berman Group reduced its stake in A by selling 6,217 shares or 1.3% in the most recent quarter. The Hedge Fund company now holds 473,102 shares of A which is valued at $22,467,614. Agilent Technologies Inc makes up approx 0.03% of Neuberger Berman Group’s portfolio.Wealthtrust-arizona boosted its stake in A in the latest quarter, The investment management firm added 1 additional shares and now holds a total of 365 shares of Agilent Technologies Inc which is valued at $17,002. Agilent Technologies Inc makes up approx 0.01% of Wealthtrust-arizona’s portfolio.
Agilent Technologies Inc opened for trading at $48.63 and hit $48.63 on the upside on Wednesday, eventually ending the session at $48.43, with a gain of 0.31% or 0.15 points. The heightened volatility saw the trading volume jump to 31,54,934 shares. Company has a market cap of $15,765 M.
On the company’s financial health, Agilent Technologies Inc reported $0.49 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 17, 2016. Analyst had a consensus of $0.47. The company had revenue of $1044.00 million for the quarter, compared to analysts expectations of $1046.16 million. The company’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.44 EPS.
Many Wall Street Analysts have commented on Agilent Technologies Inc. Company shares were Reiterated by Jefferies on May 17, 2016 to “Buy”, Firm has raised the Price Target to $ 51 from a previous price target of $46 .Company shares were Reiterated by Barclays on May 17, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 45 from a previous price target of $42 .
Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.